OUR PIPELINE

BioInvent has two active projects in clinical development.

 


In addition, BioInvent has a number of research stage projects that we consider promising; especially in the field of immuno-oncology.

READ MORE

Business Focus

BioInvent is generating value for shareholders by employing its antibody and cancer biology expertise to identify antibodies with novel mechanisms-of-action and novel oncology targets. The Company employs this approach to generate therapeutic immuno-modulating antibodies that can be developed for a broad range of cancer indications. The Company plans to bring these antibodies to the clinic through its own resources and together with partners.

READ MORE

Press Releases

MEET US

20-22 Mar, 2017, BIO Spring, Barcelona, Spain

ANALYSTS

22 Feb, 2017, LifeSci Capital initiates coverage of BioInvent

SEK